Search Awardees

Versatope Therapeutics

UEI: VSMPM3EGYYA6 • CAGE: 7TEE7

Overview

Awardee Type
Parent
Company Description
Versatope is an immuno-therapeutic company that harnesses a customized biotechnology platform to delivery immunity. State of the art synthetic biology and bioinformatics are used to customize exosome-like vesicles made from probiotics. These vesicles display targets in a 3D context that activates potent immunity. Our lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19.
Keywords
Vaccine Novel Delivery Platform
Name
Versatope Therapeutics
Headquarters
Lowell, MA
United States
Federal contract and grant recipient VERSATOPE THERAPEUTICS INC (UEI VSMPM3EGYYA6, CAGE 7TEE7) is headquartered in Lowell MA. Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology). The corporation was founded in February 2017 and federally registered in February 2017.

Federal Award Analysis

Versatope Therapeutics federal award history

$-

Contracts

$-

Subcontracts

$-

Grants

$-

Subgrants

$-

Total

Interactive Stacked Bar Chart


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating
Year Contracts Subcontracts Grants Subgrants


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating

Federal Registration and Certifications

Legal Name
VERSATOPE THERAPEUTICS INC
UEI
VSMPM3EGYYA6
CAGE Code
7TEE7
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)

People

Vendor contacts at Versatope Therapeutics

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo

Contract Awards

Versatope Therapeutics prime contract awards

Grant Awards

Versatope Therapeutics direct grants